AptamiR Therapeutics
Austin, US · Founded 2012 · Delaware corporation
AptamiR Therapeutics is a US biotechnology company in pre-clinical development of microRNA-based oligonucleotide therapeutics (antagomirs), including miR-22-3p drug candidates for cardiometabolic disorders such as obesity, diabetes and fatty liver disease (MAFLD/MASH) and candidates for epithelial ovarian cancer. Its approach modulates multiple target genes simultaneously to address complex metabolic diseases and cancer.
Founders & leadership
AptamiR Therapeutics was founded in 2012 by Marc Thibonnier and M. Thibonnier.
MT
Marc ThibonnierCo-founder
MT
M. Thibonnier
PC
Philippe CamusExecutive
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2015
▶$3MraisedSep 2015 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedSep 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philippe CamusExecutive Officer, Director
- Marc ThibonnierExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $3M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does AptamiR Therapeutics do?
- AptamiR Therapeutics is a US biotechnology company in pre-clinical development of microRNA-based oligonucleotide therapeutics (antagomirs), including miR-22-3p drug candidates for cardiometabolic disorders such as obesity, diabetes and fatty liver disease (MAFLD/MASH) and candidates for epithelial ovarian cancer. Its approach modulates multiple target genes simultaneously to address complex metabolic diseases and cancer.
- Who founded AptamiR Therapeutics?
- AptamiR Therapeutics was founded by Marc Thibonnier, M. Thibonnier in 2012.
- How much funding has AptamiR Therapeutics raised?
- AptamiR Therapeutics has disclosed $3M raised across 1 round.
- Where is AptamiR Therapeutics headquartered?
- AptamiR Therapeutics is headquartered in Austin, US.